Journal of Cancer Metastasis and Treatment
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Journal of Cancer Metastasis and Treatment
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig1

From:  Sunitinib effectiveness and safety as first line treatment in metastatic renal cell carcinoma, in the Costa Rican population
Sunitinib effectiveness and safety as first line treatment in metastatic renal cell carcinoma, in the Costa Rican population

Figure 1. (A) Probability of progression-free survival in all patients: 13.7 months (95% CI: 11.24-16.16 months); (B) probability of overall survival in all patients: 21.0 months (95% CI: 13.42-28.58 months). CI: confidence interval

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Navigation
Follow Us
Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties